Evaluation in non-human primates of the safety, immunogenicity and efficacy of recombinant vaccinia viruses expressing the F or G glycoprotein of respiratory syncytial virus
- 1 December 1988
- Vol. 6 (6) , 519-524
- https://doi.org/10.1016/0264-410x(88)90104-1
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- Cytotoxic T Cell Specificity for Respiratory Syncytial Virus Proteins: Fusion Protein Is an Important Target AntigenJournal of General Virology, 1987
- Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infectionJournal of Clinical Microbiology, 1986